Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001267770 | SCV003519680 | uncertain significance | Combined immunodeficiency due to LRBA deficiency | 2022-06-16 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 973647). This missense change has been observed in individual(s) with LRBA-related conditions (PMID: 34573280). This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 2294 of the LRBA protein (p.Asp2294Asn). |
Center for Genomic Medicine, |
RCV004596432 | SCV005090624 | uncertain significance | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | |
UOSD Laboratory of Genetics & Genomics of Rare Diseases, |
RCV001267770 | SCV001424087 | uncertain significance | Combined immunodeficiency due to LRBA deficiency | 2020-05-21 | no assertion criteria provided | clinical testing |